The way that Pestel "tanked the FDA meeting" was by saying
The way that Pestel "tanked the FDA meeting" was by saying that we needed to try 350 mg before going to 700. He was concerned about safety and thought because it had never been tried in patients before with cancer and a cancer regimen that we should start with 350. I don't recall hearing that it was inside the FDA meeting. I thought it was in the hall during a shareholder meeting. At least that's what was communicated to me. A shareholder oversaw NP and P getting in a heated debate/argument about it.
While I think 350 is unnecessary, it is in the protocol even today.
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Celebrating the 19th Annual National Indie Excellence Awards The National Indie Excellence Awards (NIEA) stands at the forefront of honoring remarkable independently published books. This prestigious event has once again recognized outstanding contributions from self-published authors and small to medium-sized presses. Recognizing Quality in Independent Publishing The...
Continue Reading
Introducing Splash: The New Body Care Line for Kids Splash is an innovative body care brand specifically designed for children aged four to ten, created by the makers of Tree Hut and Baby Magic. Aimed at filling the gap between baby products and more mature body care, Splash offers a fun, approachable option for kids and their families. A Range of Exciting Products The...
Continue Reading
Understanding Cyber Threats Ahead of Major Sporting Events With the excitement of the Super Bowl LIX approaching, the intersection of cybersecurity and sports has become more pertinent than ever. Cybersecurity experts have been closely monitoring the surge in malicious activities associated with gambling and streaming during high-profile sporting events. This focus on...
Continue Reading
Strategic Inducement Grants at LENSAR LENSAR, Inc. (Nasdaq: LNSR) has recently made headlines with the announcement of strategic inducement grants aimed at nurturing talent within the company. As a leader in the medical device industry, LENSAR is committed to attracting skilled professionals to drive their innovative projects forward. The board of directors has granted...
Continue Reading
Treasure Global Inc Strengthens Leadership with New Directors Treasure Global Inc (NASDAQ: TGL), a leading technology solutions provider, has recently announced the strategic appointment of two independent directors, Mr. Leong Wei Ping and Mr. Anand Ramakrishnan, to its Board. This move is part of the Company's ongoing commitment to enhance its leadership team and...
Continue Reading
